FOCINVEZ Drug Patent Profile

✉ Email this page to a colleague

When do Focinvez patents expire, and what generic alternatives are available?

Focinvez is a drug marketed by Steriscience and is included in one NDA. There are two patents protecting this drug.

This drug has two patent family members in two countries.

The generic ingredient in FOCINVEZ is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Focinvez

A generic version of FOCINVEZ was approved as fosaprepitant dimeglumine by FRESENIUS KABI USA on June 9^th, 2016.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for FOCINVEZ?
What are the global sales for FOCINVEZ?
What is Average Wholesale Price for FOCINVEZ?

Summary for FOCINVEZ

International Patents:	2
US Patents:	2
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	3
What excipients (inactive ingredients) are in FOCINVEZ?	FOCINVEZ excipients list
DailyMed Link:	FOCINVEZ at DailyMed

Drug patent expirations by year for FOCINVEZ

Pharmacology for FOCINVEZ

Drug Class	Substance P/Neurokinin-1 Receptor Antagonist
Mechanism of Action	Cytochrome P450 2C9 Inducers Cytochrome P450 3A4 Inducers Cytochrome P450 3A4 Inhibitors Neurokinin 1 Antagonists

US Patents and Regulatory Information for FOCINVEZ

FOCINVEZ is protected by two US patents.

Patents protecting FOCINVEZ

Compositions of fosaprepitant and methods of preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Steriscience	FOCINVEZ	fosaprepitant dimeglumine	SOLUTION;INTRAVENOUS	216686-001	Aug 22, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
Steriscience	FOCINVEZ	fosaprepitant dimeglumine	SOLUTION;INTRAVENOUS	216686-001	Aug 22, 2023		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for FOCINVEZ

See the table below for patents covering FOCINVEZ around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Slovenia	3487505		⤷ Sign Up
South Korea	102592614		⤷ Sign Up
European Patent Office	4223297	ADMINISTRATION ET DOSAGE DE DIAMINOPHÉNOTHIAZINES (ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES)	⤷ Sign Up
Spain	2946165		⤷ Sign Up
Finland	3487505		⤷ Sign Up
Australia	2017301966	Administration and dosage of diaminophenothiazines	⤷ Sign Up
South Korea	20230058533	디아미노페노티아진 (diaminophenothiazines)의 투여 및 투여량 (dosage) (diaminophenothiazines dosageAdministration and Dosage of Diaminophenothiazines)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for FOCINVEZ

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0748320	08C0019	France	⤷ Sign Up	PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111
0748320	SPC/GB08/021	United Kingdom	⤷ Sign Up	PRODUCT NAME: FOSAPREPITANT AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR THE BIS(N-METHYL-D-GLUCAMINE)SALT; REGISTERED: UK EU/1/07/437/001 20080111; UK EU/1/07/437/002 20080111
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for FOCINVEZ

Pharmacology for FOCINVEZ

Patents protecting FOCINVEZ

Make Better Decisions: Try a trial or see plans & pricing